Evaluating how Blockchain can transform the Pharmaceutical and Healthcare industry

Presented by Co-lead Disa Lee Choun (UCB)In collaboration with Adama Ibrahim (Biogen) & Christopher Hart (Manchester Informatics)

What is BlockChain

§ Decentraliseddatabasesharingandstoringregistryofassetsandtransactionsacrosspeer-to-peernetwork.

§ Adecentraliseddatabaseallowsthatotherpeernetworksverifytheinformationandalsoholdthetruth,soyoumighthavetheoriginaloftheasset/databutotherswillholdthecopy,sothedataorledgerisconsideredablockandeachblockislinked,thereforecallingablockchainaseachblockhastoreferencethepreviousonetoidentifythevalidityoftheasset/transaction

§ Blockchaincanbeprivate(vettedparticipants)orpublic(anyone).

Tamperproof Transparent

Decreasebureaucracy Anonymity

Fullaudittrail

Reducemiddleman

BlockChain past and future

2009– CryptocurrencyapplicationSatoshiNakamoto500AD

2021- worth>$2Billion

2017-15%bankstouseBlockChain

2016- worth>$210Million

2013- SMARTContractapplication

2017- >500BlockChainvendors2016/17- explorationPharma/Healthcare

“InternetV2”

2015- Otherapplications

Project Scope

• IntroduceBlockChainanddescribehowitworks• Pre-requisitestoadoptBlockChain• UnderstandthequalitiesofBlockChainrelevanttothePharmasettingandthe

exampleofusecasesandapplications• ProvidehighlevelanalysisofPros/ConsofBlockChaininPharmaandHealthcare

EmergingTrends&Technology

Educatingforthefuture

Project Deliverable and Timelines

Deliverable Timelines

Provideawhitepaperthat:-IncludesanoverviewofBlockChain-AnalysesthecurrentprocessandareaswhereBlockChainwouldhavemostimpact(i.e.efficiency,changemanagement,…)-ProposesUseCaseswhereBlockchainwouldtransformthecurrentlandscape

-ResearchingBlockchainandimplementationdetails:3months-Finalisingthewhitepaper:6-9months

Communicationplan:Publication,presentation,andwebinars

Propose presentation-DIA inJune2018-PhUSEConferenceinJune2018-Others(tbd)

Project members

• Co-leads: – Adama Ibrahim (Biogen)– Christopher Hart (Manchester

Informatics)– Disa Lee Choun (UCB)

• Members:– Maria Berjegard (Aztra Zeneca)– Marcus Bjareland (Aztra Zeneca)– Farzad Faramarzi (Aztra Zeneca)– Kerstin Forsberg (Aztra Zeneca)– Hariprasad Radhakrishnan (Aztra

Zeneca)– Anders Bergkvist (Merck)

– Bert Hartog (Johnson&Johnson)– Zakaria Arrassi (UCB)– Ellen Vermaere (UCB)

RegulatorySME

ITBlockChainSME

Thank you